Product Liability Archive » April, 2008

Product Liability - April, 2008

159 articles

• 'Cutter' Convicted Of Stealing Human Tissue
• Baycol Whistleblower Suit Unsealed In N.J. Court
• Cargill, National Beef Cited For Mishandling Cattle
• Philly Corpse Harvesters Face Lawsuit From Families
• NYSRA Dealt Heavy Blow In Calorie War
• CPSC Reform Legislation Needs Funding, Says Agency
• Proof Of Causation In Recent Product Liability Cases
• Texas Looks Again At Preemption Of Tort Lawsuits
• Widow's $11M Medtronic Claims Time-Barred: Court
• EPA Risk Assessment Is Too Political: Democrats
• FDA Panel Says LASIK Merits Stronger Warnings
• Chicago Sidesteps Fire Trial With $50M Deal
• Lawmakers Push FDA To Detail Needed Reforms
• Class Certification In Consumer Product RICO Cases
• Second Circuit Weighs Calorie-Posting Stay
• Actavis Recalls Drug Over Possibly Deadly Defect
• Port Authority Liable In 1993 Attack: Appeals Court
• Jury Tells Honeywell To Pay $24M In Asbestos Case
• FDA Passes New Rule On Foreign Drug Trials
• Bill Would Allow Private Suits Over Pollution
• Medtronic Unit Reaches Deal With FDA
• Tyson False Advertising Suit Sparks Class Action
• Scruggs' Ex-Partner Wants $15M Fee Case Reopened
• Bayer Faces 78 Trasylol Suits, CEO Says
• NuvaRing Plaintiffs Lobby For MDL
• FDA Proposes Funding Plans For Animal-Drug Reviews
• Eli Lilly's 'Restless Leg' Drug Permax Hits The Skids
• Rhode Island Neighborhood Settles With Utility
• Chicago Fire Victims Reach $25M Deal On Trial's Eve
• Judge Keeps Device Suit V. Boston Scientific Alive
• Judge Keeps Cessna Canadian Crash Case In U.S.
• FDA Passes Rule On Cattle Use In Animal Feed
• Miracle-Gro Recalls Unregistered Pesticides
• FDA Official Tells Senators Agency Can't Keep Up
• Judge Tells NYC To Hold The Calorie Info
• Tyson's 'No Antibiotics' Claims Untrue, Court Says
• Del. Courts Best For Tort, Contract Litigation: Study
• Synthes Suffers One-Two Punch In Prodisc Suit
• N.J. Jury Awards $10.5M In Third Accutane Trial
• Maltose Falsely Elevated Diabetics' Readings: FDA
• Does Riegel V. Medtronic Affect You?
• Doctors To Speak For Both Sides In Fen-Phen Trial
• Appeals Court Revives Parents' Suit Against Gerber
• Zyprexa Attorneys Come Up Short in Fee Request
• Japan Shuts Out Beef From California Plant
• FDA Finds New Data Linking Bad Heparin To China
• FDA Warns Philips After Plant Inspections
• Court Chucks 9/11 Liability Suit Against Ex-EPA Chief
• GAO Slams FDA Inspection Process
• Pfizer's Viagra Video Spurs FDA Reprimand
• FDA Says Its Foreign Inspections Need A Face-Lift
• Medical Device Ruling Will Have Broad Impact
• USDA May Post Names Of Stores In Meat Recalls
• Retailers Yank BPA Products Amid Cancer Fears
• Texas Jury Issues $84M Verdict Against U-Haul
• China Eyes Life Sentence For Producing Unsafe Food
• High Court Rejects Another Exxon Damages Case
• High Court Will Not Take On Benlate Case
• Parkinson's And Pesticide Link Grows Stronger
• Insurance Cos. Sue For Piece Of Vioxx Settlement
• Zyprexa Master Subpoenaed For Seroquel Case
• FDA Reaffirms Bioequivalence Of Wellbutrin Generic
• House Democrats Propose Drug Import Reforms
• First Circ. Revives Boston Scientific Securities Suit
• Bush Official Defends USDA Meat Inspection System
• Pfizer, Plaintiffs Spar Over Evidence
• FDA Issues New Rules On Cattle Use In Food, Makeup
• Scruggs' Misdeeds Continue To Have Ripple Effects
• Debate Brews Over Tolling Rule In Mass Tort Cases
• Key Pharma Preemption Ruling In 3rd Circuit
• Dying Asbestos Plaintiffs Call For Mediation
• Full Speed Ahead For Ford Rollover Settlement
• FDA Drug Tracking Unlikely To Improve: Attorneys
• EPA Changes Of Toxic Risk Assessment Draw Fire
• Judge OKs NYC Plan On Calorie Displays
• Lawyers Win $218M In Defunct Tobacco Class Action
• Federal Courts See Huge Rise In Class Actions
• FDA Suspects Fraud Led To Heparin Contamination
• Federal-Mogul Trust Seeks To Halt Claimant Group
• Court Sides With Insurers In Hurricane Katrina Action
• WellPoint Hoping To Catch Drug Side Effects Sooner
• Former Court Commissioner Joins McCarter & English
• Chemical May Be Linked To Health Problems: Study
• Group Files USDA Complaint Over Baby Formula
• Merck Knew About Vioxx Dangers For Years: Report
• More Calif. Wildfire Victims File Negligence Suits
• Committee Answers Medtronic Plaintiffs' Objections
• Monsanto, 3M, Others Targeted By Cancer Victim
• Taser Beats Another Product Liability Suit
• Okla. Miner Faces Class Action Over Contaminants
• Insurers Cry Foul Over Congoleum's Chapter 11 Plan
• FDA Tentatively Ties Salmonella To Cereal Recall
• Institute Fights Subpoena For Auto Transmission Info
• MDL Created For Nissan Odometer Cases
• Body Armor Co. Staves Off Suit With $960K Deal
• FDA Watch Over Natural Supplements Growing Keener
• Mass. Superfund Plaintiffs May Face Double Trouble
• Appeals Court Throws Out Costly Tobacco Case
• False Advertising Suit Against Tyson To Move Forward
• Companies Fined For Selling Non-DTV Ready TVs
• Genzyme Recalls Murky Batches Of Transplant Drug
• EPA Holds Off On Regulating Drugs In Water Supply
• FDA Probes Roche, Novartis Drugs' Link To Disorder
• Bextra Plaintiffs Blast Summary Judgment Motion
• Couple Heads To Court Over Alleged Gas Injury
• MDL Panel Opts To Centralize Vytorin Litigation
• Health Canada To Investigate Relenza
• Cubist Finds Contaminant In Popular Antibiotic
• Canadian Class Certified Over Guidant Medical Devices
• Halted Cancer Drug Trials May Harm Patients: Study
• Canada Wants In On Asbestos Claims V. Grace
• Chrysler Hit With $5M Verdict Over Baby's Death
• FDA Links More Deaths To Heparin
• Court Backs Drug Cos. In Suicide Cases
• 8th Circ. Decertifies Class In St. Jude Valve Case
• Lung Cancers Prompt Pfizer To Revise Exubera Label
• State Farm Aims At Whistleblowing Scruggs Clients
• Boston Scientific Snags Medical Device Bigwig
• FDA Censures Glaxo Over Flawed Avandia Reports
• Court Revives Tort Firm's Case Against AIG
• FDA Precludes Expert Testimony On Ortho-Evra: J&J
• 7 Traps To Avoid When Using Expert Witnesses
• Judge Grants $430M In Fen-Phen Attorneys' Fees
• Calif. Ruling Will Affect Defense Of Future Cases
• Japanese Cos. Sanctioned Over 'Recycled' Paper
• J&J, Ortho-Evra Plaintiffs Duel Over Experts
• 5th Circuit Overturns $1M Hurricane Katrina Decision
• Zimmer Recalls Surgical Products After Inspection
• W.R. Grace To Pay $1.8B In Asbestos Settlement
• Ethanol Fuel Harms Boat Engines, Lawsuit Claims
• Expert Testimony - Admit Or Preclude?
• Plaintiffs' Attorneys Booted From Katrina Suits
• Dangerous Products Could Be 'Double Trouble'
• Lawyer Loses Appeal In Partnership Dispute
• Vytorin Headache Grows With Shareholder Suit
• Viagra Judge Strikes Expert's Testimony
• $20M Closes PG&E's 'Erin Brockovich' Chapter
• Calif. High Court Approves Limited Product Warnings
• Objections Force FDA To Withdraw New Rules
• Novartis Makes Drug Available Only In Dire Situations
• Utah Miners' Families Seek Recompense
• Class Decertified In $800B 'Light' Cigarettes Case
• Judge Sides With Novartis In Aredia, Zometa MDL
• Tobacco Litigation Veterans Join King & Spalding
• Expert Says FEMA Knew About Trailer Toxicity
• Acting Attorney General Goes Home To Sidley
• Judge Quashes Immediate Appeal In Hormone Case
• House Committee Approves Tobacco Regulation Bill
• Chevron Could Face $16B Bill For Amazon Pollution
• J&J, Amgen Scrutinized For Anemia Drug Marketing
• TJX Reaches $24M Deal With MasterCard Issuers
• King & Spalding Adds Drinker Biddle Partners In Calif.
• Celebrex Linked To Increased Heart Attack Risk
• Mississippi Bar Lashes Out At Scruggs
• W.R. Grace Judge Declines To Shield Montana
• St. Jude Knowingly Marketed Faulty Leads: Suit
• Tentative Settlement Reached In Pet Food MDL
• EPA Beefs Up Lead-Paint Rules
• Novartis Plays Down Impact Of Split High Court Ruling